TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study.

H S Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.